semaglutide mw 10mg Semaglutide GLP-1 Receptor Agonist Research

Lower costs mean more people can finally get access

Pharmacists Perspective We asked Alessandro Grenci, Superintendent Pharmacist at Medino , for his professional take: "Cold sensitivity is a commonly reported experience on Wegovy

Lancet Neurol, 13:885-892

2026 Breakthrough: The First Oral GLP-1 Pill for Weight Loss In December 2025, the FDA approved an oral form of semaglutide (Wegovy Pill) at a 25 mg daily dosemaking it the first GLP-1 medication available as a pill rather than an injection for weight management

The goal is to maintain hemoglobin A1c below 7% for most adults, though individualized targets may vary based on age, comorbidities, and hypoglycemia risk, according to the ADA Standards of Care

By mimicking the natural hormone amylin, Cagrilintide delays gastric emptying and enhances satiety, leading to reduced caloric intake and better portion control during meals